This week on the “CURE® Talks Cancer” podcast, to kick off Colorectal Cancer Awareness Month, we spoke with colon cancer survivor April Schack about what it was like to be diagnosed at age 36 and how she’s working with Fight CRC on a new campaign that aims to raise awareness about the disease, so that no one has to go through what she did.
Women with a history of depression had higher rates of cancer-related fatigue, according to recent study results.
This approval expands a previous accelerated approval of the drug in 2018, allowing it for use in patients with brain metastases.
Patients treated with Imbruvica plus TG-1101 had an overall response rate of 83% compared with 65% in those treated with Imbruvica alone.
A caregiver offers new caregivers tips on how to become an active part of a loved one’s cancer care team.
The results, according to the study authors, should be reassuring to patients who may have been concerned about the risk of contracting the virus that causes COVID-19 from surfaces in cancer centers.
Even as chemotherapy, surgery and radiation remain treatment mainstays, immunotherapy is ready to take the stage.
The data, according to the study authors, confirm a recent Food and Drug Administration approval of the regimen and support its use in the front-line treatment of patients with advanced non-small cell lung cancer.
Patients with prostate and breast cancer may be unknowingly putting themselves at risk while taking herbs and supplements during chemotherapy and should consult their medical team before using them, according to an expert.
A cancer survivor laments the fact that she no longer moves as fast as she once did when she was younger. However, she has come to the realization that moving slow is OK as it allows her to enjoy life.
An expert from the Roswell Park Comprehensive Cancer Center recommends that patients with cancer get whichever vaccine is available at the time they go to get vaccinated.
A young mother and athlete discusses receiving a shocking diagnosis of stage 4 lung cancer and her incredible response to treatment with a single, targeted drug.
A patient with recurrent basal cell carcinoma discusses his cancer journey, his latest challenge and how he’s now prioritized quality of life over quantity.
On social media, CURE® recently asked its readers to share what they want to hear from family and friends and what they don’t want to hear.
An oncology nurse offers people tips on how to find the courage and be better advocates to their loved ones who may be receiving treatment for cancer.
Although a gynecologic oncologist has spent a good part of her career helping patients during their cancer journeys, she took it upon herself to take one step further to educate women on how they can advocate for themselves and potentially prevent cancer before it impacts their lives.
Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for February 2021.
Call volumes increased to jaw-dropping numbers during the beginning of the pandemic, and this cancer survivor hopes that trend continues even after we are out of the pandemic.
It’s always best to have a team of people, whether friends or family, rooting us on as we face whatever challenges come our way.
The Johnson & Johnson vaccine is delivered in a single dose, which is a departure from the two doses required for the already available Pfizer-BioNTech and Moderna vaccines.
A patient with metastatic breast cancer recalls how she’s been told countless times that she’s so brave, so strong and so resilient. Here, she thanks those who have influenced her and helped her be so courageous.
Over the past decade, advances in both diagnostics and therapeutics in a variety of blood cancers have turned certain diseases into chronic conditions.
The agency granted accelerated approval to Pepaxto in combination with dexamethasone in adult patients with relapsed or refractory multiple myeloma, who received at least four prior lines of therapy.
A roundup of some of the latest news and updates for patients with ovarian cancer from CURE®.
Throughout the winter, the FDA has continued to approve several new agents to treat a variety of cancers. Here are five recent approvals that patients with cancer may have missed.
A cancer survivor recalls his experience with a life-threatening infection following surgery to remove his tumor and notes how it influenced his decision to get a COVID-19 vaccine.
From a childhood cancer survivor being named a member of the first all-civilian SpaceX mission to colorectal cancer survivors golfing alongside PGA Tour champions in the Cologuard Classic, here’s what’s happening in the cancer space this week.
Results from the phase 2 KarMMa trial showed that 73% of patients had a response to the CAR-T cell therapy, including 33% who experienced a complete response or better.
Following resection with radiotherapy increased survival rates for patients compared with those who did not receive the additional treatment.
Although most patients reported satisfaction after undergoing a mastectomy without breast reconstruction surgery, 20.7% of women felt that their surgeon was not supportive of their decision to do so.
